Risk factor
Very poor trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Nexstim Plc, a medical technology company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's proprietary SmartFocus technology with 3D navigation is the navigated transcranial magnetic stimulation (TMS) approach that is used for therapeutic and diagnostic applications. It offers NBT system, a...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.
Target Price
The average target price of NXTMH.HE is 12 and suggests 30% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell